Emodin represses TWIST1-induced epithelial-mesenchymal transitions in head and neck squamous cell carcinoma cells by inhibiting the β-catenin and Akt pathways

European Journal of Cancer

Volumn 50, Issue 2, 2014, Pages 366-378

  Way, Tzong Der ^a,b   Huang, Jhen Ting ^a   Chou, Chun Hung ^c   Huang, Chi Hung ^d,e   Yang, Muh Hwa ^c,f   Ho, Chi Tang ^g  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b ASIA UNIVERSITY   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

^d Taiwan Advance Biopharm ^*  (Taiwan)

^e HUNGKUANG UNIVERSITY   (Taiwan)

^f TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^g RUTGERS UNIVERSITY   (United States)

Author keywords

Emodin; Epithelial mesenchymal transition; Head and neck squamous cell carcinoma; TWIST1

Indexed keywords

BETA CATENIN; EMODIN; HERMES ANTIGEN; MESSENGER RNA; TRANSCRIPTION FACTOR TWIST; TRANSCRIPTION FACTOR TWIST1; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN;

ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; DOWN REGULATION; ENZYME INHIBITION; EPITHELIAL MESENCHYMAL TRANSITION; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN CELL; IN VIVO STUDY; METASTASIS INHIBITION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; TRANSCRIPTION TERMINATION; TUMOR INVASION; UPREGULATION;

EID: 84891836385     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2013.09.025     Document Type: Article

References (37)

1. A. Jemal, R. Siegel, J. Xu, and E. Ward Cancer statistics, 2010 CA Cancer J Clin 60 2010 277 300
2. J.P. Thiery, H. Acloque, R.Y. Huang, and M.A. Nieto Epithelial mesenchymal transitions in development and disease Cell 139 2009 871 890
3. T. Brabletz, A. Jung, S. Spaderna, F. Hlubek, and T. Kirchner Opinion: migrating cancer stem cells - an integrated concept of malignant tumour progression Nat Rev Cancer 5 2005 744 749
4. J.M. Lee, S. Dedhar, R. Kalluri, and E.W. Thompson The epithelial-mesenchymal transition: new insights in signaling, development, and disease J Cell Biol 172 2006 973 981
5. J. Yang, S.A. Mani, and J.L. Donaher et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis Cell 117 2004 927 939
6. M.H. Yang, M.Z. Wu, and S.H. Chiou et al. Direct regulation of TWIST by HIF-1α promotes metastasis Nat Cell Biol 10 2008 295 305
7. B. Keith, and M.C. Simon Hypoxia-inducible factors, stem cells and cancer Cell 129 2007 465 472
8. M.M. Nijkamp, P.N. Span, I.J. Hoogsteen, A.J. van der Kogel, J.H. Kaanders, and J. Bussink Expression of E-cadherin and vimentin correlates with metastasis formation in head and neck squamous cell carcinoma patients Radiother Oncol 99 2011 344 348
9. C. Chen, Y. Wei, and M. Hummel et al. Evidence for epithelial-mesenchymal transition in cancer stem cells of head and neck squamous cell carcinoma PLoS One 6 2011 e16466
10. J.E. Visvader, and G.J. Lindeman Cancer stem cells in solid tumours: accumulating evidence and unresolved questions Nat Rev Cancer 8 2008 755 768
11. S.A. Mani, W. Guo, and M.J. Liao et al. The epithelial-mesenchymal transition generates cells with properties of stem cells Cell 133 2008 704 715
12. M.E. Prince, R. Sivanandan, and A. Kaczorowski et al. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma Proc Natl Acad Sci U S A 104 2007 973 978
13. L.O. Demirezer, A. Kuruüzüm-Uz, I. Bergere, H.J. Schiewe, and A. Zeeck The structures of antioxidant and cytotoxic agents from natural source: anthraquinones and tannins from roots of Rumex patientia Phytochemistry 58 2001 1213 1217
14. Q. Huang, G. Lu, H.M. Shen, M.C. Chung, and C.N. Ong Anti-cancer properties of anthraquinones from rhubarb Med Res Rev 27 2007 609 630
15. J. Li, P. Liu, H. Mao, A. Wanga, and X. Zhang Emodin sensitizes paclitaxel-resistant human ovarian cancer cells to paclitaxel-induced apoptosis in vitro Oncol Rep 21 2009 1605 1610
16. J.C. Ko, Y.J. Su, and S.T. Lin et al. Suppression of ERCC1 and Rad51 expression through ERK1/2 inactivation is essential in emodin-mediated cytotoxicity in human non-small cell lung cancer cells Biochem Pharmacol 79 2010 655 664
17. W. Chun-Guang, Y. Jun-Qing, and L. Bei-Zhong et al. Anti-tumor activity of emodin against human chronic myelocytic leukemia K562 cell lines in vitro and in vivo Eur J Pharmacol 627 2010 33 41
18. Y.Y. Chen, S.Y. Chiang, and J.G. Lin et al. Emodin, aloe-emodin and rhein inhibit migration and invasion in human tongue cancer SCC-4 cells through the inhibition of gene expression of matrix metalloproteinase-9 Int J Oncol 36 2010 1113 1120
19. L.C. Liu, T.C. Tsao, and S.R. Hsu et al. EGCG inhibits transforming growth factor-β-mediated epithelial-to-mesenchymal transition via the inhibition of Smad2 and Erk1/2 signaling pathways in nonsmall cell lung cancer cells J Agric Food Chem 60 2012 9863 9873
20. T. Chiba, S. Miyagi, and A. Saraya et al. The polycomb gene product BMI1 contributes to the maintenance of tumor-initiating side population cells in hepatocellular carcinoma Cancer Res 68 2008 7742 7749
21. M.H. Yang, D.S. Hsu, and H.W. Wang et al. Bmi1 is essential in Twist1-induced epithelial-mesenchymal transition Nat Cell Biol 12 2010 982 992
22. H. Clevers, and R. Nusse Wnt/β-catenin signaling and disease Cell 149 2012 1192 1205
23. T. Masaki, A. Goto, and M. Sugiyama et al. Possible contribution of CD44 variant 6 and nuclear beta-catenin expression to the formation of budding tumor cells in patients with T1 colorectal carcinoma Cancer 92 2001 2539 2546
24. G.Z. Cheng, J. Chan, Q. Wang, W. Zhang, C.D. Sun, and L.H. Wang Twist transcriptionally up-regulates AKT2 in breast cancer cells leading to increased migration, invasion, and resistance to paclitaxel Cancer Res 67 2007 1979 1987
25. A. Singh, and J. Settleman EMT, cancer stem cells and drug resistance. An emerging axis of evil in the war on cancer Oncogene 29 2010 4741 4751
26. Z. Wang, Y. Li, and A. Ahmad et al. Targeting miRNAs involved in cancer stem cell and EMT regulation: an emerging concept in overcoming drug resistance Drug Resist Updat 13 2010 109 118
27. M. Santisteban, J.M. Reiman, and M.K. Asiedu et al. Immune-induced epithelial to mesenchymal transition in vivo generates breast cancer stem cells Cancer Res 69 2009 2887 2895
28. A.P. Morel, M. Lièvre, C. Thomas, G. Hinkal, S. Ansieau, and A. Puisieux Generation of breast cancer stem cells through epithelial-mesenchymal transition PLoS One 3 2008 e2888
29. A. Smith, T.N. Teknos, and Q. Pan Epithelial to mesenchymal transition in head and neck squamous cell carcinoma Oral Oncol 49 2013 287 292
30. K.M. Hajra, D.Y. Chen, and E.R. Fearon The SLUG zinc-finger protein represses E-cadherin in breast cancer Cancer Res 62 2002 1613 1618
31. M.A. Perez-Moreno, A. Locascio, and I. Rodrigo et al. A new role for E12/E47 in the repression of E-cadherin expression and epithelial-mesenchymal transitions J Biol Chem 276 2001 27424 27431
32. A. Eger, K. Aigner, and S. Sonderegger et al. DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells Oncogene 24 2005 2375 2385
33. B.P. Zhou, J. Deng, and W. Xia et al. Dual regulation of Snail by GSK-3beta-mediated phosphorylation in control of epithelial mesenchymal transition Nat Cell Biol 6 2004 931 940
34. C. Liu, Y. Li, and M. Semenov et al. Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism Cell 108 2002 837 847
35. K. Kim, Z. Lu, and E.D. Hay Direct evidence for a role of beta-catenin/LEF-1 signaling pathway in induction of EMT Cell Biol Int 26 2002 463 476
36. N.R. Alexander, N.L. Tran, H. Rekapally, C.E. Summers, C. Glackin, and R.L. Heimark N-cadherin gene expression in prostate carcinoma is modulated by integrin-dependent nuclear translocation of Twist1 Cancer Res 66 2006 3365 3369
37. M.Z. Wu, Y.P. Tsai, and M.H. Yang et al. Interplay between HDAC3 and WDR5 is essential for hypoxia-induced epithelial-mesenchymal transition Mol Cell 43 2011 811 822